Medical Airlifts Less Likely For Minorities

Follow Drugslib on

Medically reviewed by Drugs.com.

By Dennis Thompson HealthDay Reporter

MONDAY, Jan. 27, 2025 -- Time is of the essence during a medical emergency, and helicopter transport often is essential to saving a patient teetering near death.

Unfortunately, Black, Asian and Hispanic people with life-threatening injuries are significantly less likely than white patients to be airlifted to a trauma center, according to a study published Jan. 22 in JAMA Surgery.

“Trauma is one of the leading causes of death in the U.S. and helicopter transport can make the difference between life and death by getting patients to the right care as quickly as possible,” said senior researcher Dr. Olubukola Nafiu, vice chair of research in anesthesiology at the Montefiore Medical Center and Albert Einstein College of Medicine in Bronx, N.Y.

The study’s results highlight “inequities in emergency care,” Nafiu added in a news release.

Severe trauma is best treated within what doctors call the “golden hour” after an accident, but more than a quarter of U.S. residents require helicopter transport to get them to a trauma center under that deadline, researchers said in background notes.

For the study, researchers analyzed records for more than 341,000 severely injured adults treated at 458 U.S. trauma centers between 2016 and 2022.

Nearly 22% of white patients requiring urgent surgery or ICU care received helicopter transport to a trauma center, results show.

By comparison, only 7% of Asian patients, 9% of Black patients and 11% of Hispanic patients were airlifted, even though their injuries were comparable to those of the white patients, researchers said.

These disparities persisted throughout the study period, “challenging the effectiveness of current efforts to expand helicopter ambulance programs,” researchers wrote in their paper.

“Even against a backdrop of increasing awareness of health care disparities in the US, we found no evidence that the racial and ethnic gaps in use of helicopter transport were narrowing over time, indicating that the recent expansion of helicopter ambulances has not translated into equitable access for all racial and ethnic groups,” the researchers added.

Access to air ambulance transport might be expanded by providing better training and tools to paramedics, researchers wrote.

“The role of EMS personnel in determining the optimal transport strategy cannot be overstated,” researchers wrote.

For example, applying evidence-based triage tools in a colorblind way could ensure that “patients who are most likely to benefit from helicopter transport, including potentially underserved racial and ethnic minority patients, will be more likely to receive it,” researchers wrote.

In an accompanying editorial, Dr. Cherisse Berry agreed that “eliminating disparities in access to care, particularly time-sensitive emergency care, is critical to achieving health equity for everyone.”

“Expeditious transport of critically injured patients by emergency medical services to verified trauma centers for definitive care can be the difference between survival, severe disability, and death,” wrote Berry, a surgeon with the Rutgers New Jersey Medical School in Newark. “Thus, in the trauma care chain of survival, the prehospital phase of care is the most critical link in minimizing disability and preventable death after injury.”

Sources

  • Montefiore Medical Center and Albert Einstein College of Medicine, news release, Jan. 22, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-01-28 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords